You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Sciegen Pharms Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for SCIEGEN PHARMS INC, and what generic and branded alternatives to SCIEGEN PHARMS INC drugs are available?

SCIEGEN PHARMS INC has sixty-three approved drugs.



Summary for Sciegen Pharms Inc
US Patents:0
Tradenames:47
Ingredients:46
NDAs:63

Drugs and US Patents for Sciegen Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sciegen Pharms Inc PREGABALIN pregabalin TABLET, EXTENDED RELEASE;ORAL 215675-003 Sep 14, 2022 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Sciegen Pharms Inc METAXALONE metaxalone TABLET;ORAL 207466-001 Aug 31, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Sciegen Pharms Inc HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 205236-002 May 26, 2017 AA RX No No ⤷  Try a Trial ⤷  Try a Trial
Sciegen Pharms Inc PRAMIPEXOLE DIHYDROCHLORIDE pramipexole dihydrochloride TABLET;ORAL 203855-001 Oct 28, 2014 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Sciegen Pharms Inc CLOPIDOGREL BISULFATE clopidogrel bisulfate TABLET;ORAL 204165-002 Sep 15, 2014 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Sciegen Pharms Inc SERTRALINE HYDROCHLORIDE sertraline hydrochloride TABLET;ORAL 076442-003 Apr 30, 2007 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Sciegen Pharms Inc LISINOPRIL lisinopril TABLET;ORAL 212041-002 Sep 15, 2020 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.